CASP3 and Alzheimer disease: In 2016, Wang et al. demonstrated that genistein exerts beneficial effects against cognitive deficits probably by downregulating Bax/cyt c/caspase-3-mediated apoptotic signaling in the hippocampus at 49 days after Aβ25–35-induced AD [15].